

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | histone H3-K4 trimethylation (GO:0080182) | 3.87028167 |
| 2 | cellular response to ethanol (GO:0071361) | 3.80664169 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.77880827 |
| 4 | microglial cell activation (GO:0001774) | 3.74745496 |
| 5 | detection of molecule of bacterial origin (GO:0032490) | 3.69688291 |
| 6 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.64908002 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.64684689 |
| 8 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.64361087 |
| 9 | establishment of protein localization to Golgi (GO:0072600) | 3.62454069 |
| 10 | macrophage activation involved in immune response (GO:0002281) | 3.52388120 |
| 11 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.50788824 |
| 12 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.50788824 |
| 13 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.50788824 |
| 14 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.47750398 |
| 15 | protein targeting to Golgi (GO:0000042) | 3.43451388 |
| 16 | interferon-gamma production (GO:0032609) | 3.39484036 |
| 17 | positive regulation of granulocyte differentiation (GO:0030854) | 3.33364689 |
| 18 | positive T cell selection (GO:0043368) | 3.31289750 |
| 19 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.26090204 |
| 20 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.23598161 |
| 21 | negative regulation of cell killing (GO:0031342) | 3.23598161 |
| 22 | negative regulation of interleukin-12 production (GO:0032695) | 3.23036306 |
| 23 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.22392102 |
| 24 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 3.21091807 |
| 25 | negative T cell selection (GO:0043383) | 3.19355296 |
| 26 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.18532628 |
| 27 | regulation of regulatory T cell differentiation (GO:0045589) | 3.12960628 |
| 28 | regulation of DNA endoreduplication (GO:0032875) | 3.07973070 |
| 29 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.05949494 |
| 30 | histone H3-K36 demethylation (GO:0070544) | 3.02333831 |
| 31 | B cell receptor signaling pathway (GO:0050853) | 3.01912861 |
| 32 | hepatocyte apoptotic process (GO:0097284) | 3.01770633 |
| 33 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 3.00635168 |
| 34 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.99176045 |
| 35 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.98820160 |
| 36 | macrophage activation (GO:0042116) | 2.97713716 |
| 37 | mitotic sister chromatid cohesion (GO:0007064) | 2.96069244 |
| 38 | T cell selection (GO:0045058) | 2.94252719 |
| 39 | cellular extravasation (GO:0045123) | 2.94220741 |
| 40 | alpha-beta T cell differentiation (GO:0046632) | 2.89024181 |
| 41 | neutrophil mediated immunity (GO:0002446) | 2.86386727 |
| 42 | detection of external biotic stimulus (GO:0098581) | 2.84994744 |
| 43 | negative regulation of B cell proliferation (GO:0030889) | 2.84719460 |
| 44 | negative thymic T cell selection (GO:0045060) | 2.83635087 |
| 45 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.82834685 |
| 46 | alpha-beta T cell activation (GO:0046631) | 2.81746398 |
| 47 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.81177950 |
| 48 | positive regulation by symbiont of host defense response (GO:0052509) | 2.80176661 |
| 49 | modulation by symbiont of host defense response (GO:0052031) | 2.80176661 |
| 50 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.80176661 |
| 51 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.80176661 |
| 52 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.80176661 |
| 53 | modulation by symbiont of host immune response (GO:0052553) | 2.80176661 |
| 54 | myeloid leukocyte mediated immunity (GO:0002444) | 2.79462660 |
| 55 | neural tube formation (GO:0001841) | 2.73155593 |
| 56 | protein K11-linked deubiquitination (GO:0035871) | 2.72799796 |
| 57 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.72739492 |
| 58 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.72084935 |
| 59 | T-helper cell differentiation (GO:0042093) | 2.71987737 |
| 60 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.71987737 |
| 61 | positive regulation of tolerance induction (GO:0002645) | 2.69780518 |
| 62 | tolerance induction (GO:0002507) | 2.68616383 |
| 63 | regulation of T cell tolerance induction (GO:0002664) | 2.68077713 |
| 64 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.67842603 |
| 65 | histone H3-K4 methylation (GO:0051568) | 2.67295380 |
| 66 | CD4-positive, alpha-beta T cell activation (GO:0035710) | 2.67223789 |
| 67 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.67206844 |
| 68 | peptidyl-lysine trimethylation (GO:0018023) | 2.66640590 |
| 69 | negative regulation of adaptive immune response (GO:0002820) | 2.65167129 |
| 70 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.63716048 |
| 71 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.61115063 |
| 72 | positive regulation of defense response to virus by host (GO:0002230) | 2.60986573 |
| 73 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.60225599 |
| 74 | natural killer cell activation involved in immune response (GO:0002323) | 2.59913286 |
| 75 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.59502479 |
| 76 | neutrophil activation (GO:0042119) | 2.59253289 |
| 77 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 2.59061248 |
| 78 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 2.59061248 |
| 79 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.58069903 |
| 80 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.58069903 |
| 81 | regulation of tolerance induction (GO:0002643) | 2.56873099 |
| 82 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.56420773 |
| 83 | defense response to protozoan (GO:0042832) | 2.54863175 |
| 84 | histone H3-K9 demethylation (GO:0033169) | 2.54537118 |
| 85 | cellular response to exogenous dsRNA (GO:0071360) | 2.54423486 |
| 86 | macroautophagy (GO:0016236) | 2.54303249 |
| 87 | myeloid cell activation involved in immune response (GO:0002275) | 2.53836775 |
| 88 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.52957520 |
| 89 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.52745420 |
| 90 | response to interferon-alpha (GO:0035455) | 2.52685997 |
| 91 | I-kappaB phosphorylation (GO:0007252) | 2.50992584 |
| 92 | positive regulation of mRNA catabolic process (GO:0061014) | 2.49716215 |
| 93 | cellular response to interleukin-15 (GO:0071350) | 2.48991894 |
| 94 | response to host defenses (GO:0052200) | 2.48253734 |
| 95 | regulation of protein polyubiquitination (GO:1902914) | 2.48106575 |
| 96 | V(D)J recombination (GO:0033151) | 2.48089112 |
| 97 | regulation of gamma-delta T cell activation (GO:0046643) | 2.45371590 |
| 98 | histone H3-K9 methylation (GO:0051567) | 2.43089641 |
| 99 | detection of other organism (GO:0098543) | 2.42447749 |
| 100 | B cell proliferation (GO:0042100) | 2.40734529 |
| 101 | granulocyte activation (GO:0036230) | 2.37658000 |
| 102 | response to type I interferon (GO:0034340) | 2.36937150 |
| 103 | positive thymic T cell selection (GO:0045059) | 2.35692372 |
| 104 | T cell differentiation involved in immune response (GO:0002292) | 2.33972610 |
| 105 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.33972610 |
| 106 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.33972610 |
| 107 | dendritic cell chemotaxis (GO:0002407) | 2.32848178 |
| 108 | nuclear pore complex assembly (GO:0051292) | 2.32717391 |
| 109 | dendritic cell migration (GO:0036336) | 2.30692884 |
| 110 | type I interferon signaling pathway (GO:0060337) | 2.30161911 |
| 111 | cellular response to type I interferon (GO:0071357) | 2.30161911 |
| 112 | positive regulation of interleukin-2 production (GO:0032743) | 2.29750611 |
| 113 | response to muramyl dipeptide (GO:0032495) | 2.29270505 |
| 114 | activated T cell proliferation (GO:0050798) | 2.28256360 |
| 115 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.28014137 |
| 116 | response to host immune response (GO:0052572) | 2.27665028 |
| 117 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.27665028 |
| 118 | definitive hemopoiesis (GO:0060216) | 2.27237158 |
| 119 | T cell migration (GO:0072678) | 2.26367224 |
| 120 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.26218147 |
| 121 | cellular response to interferon-alpha (GO:0035457) | 2.26196209 |
| 122 | germinal center formation (GO:0002467) | 2.26170846 |
| 123 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.26104122 |
| 124 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.24986863 |
| 125 | positive regulation of interferon-alpha production (GO:0032727) | 2.24140971 |
| 126 | thymic T cell selection (GO:0045061) | 2.22310833 |
| 127 | regulation of activation of Janus kinase activity (GO:0010533) | 2.21828189 |
| 128 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.20373045 |
| 129 | T cell differentiation (GO:0030217) | 2.19083650 |
| 130 | positive regulation of interleukin-12 production (GO:0032735) | 2.18843738 |
| 131 | modulation by symbiont of host cellular process (GO:0044068) | 2.18837644 |
| 132 | T-helper 1 type immune response (GO:0042088) | 2.17962799 |
| 133 | replicative senescence (GO:0090399) | 2.17480008 |
| 134 | regulation of mRNA catabolic process (GO:0061013) | 2.16913009 |
| 135 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.16630641 |
| 136 | regulation of interferon-alpha production (GO:0032647) | 2.15762003 |
| 137 | histone lysine demethylation (GO:0070076) | 2.15681996 |
| 138 | negative regulation of T cell mediated immunity (GO:0002710) | 2.13345819 |
| 139 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.12818407 |
| 140 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.12818407 |
| 141 | regulation of germinal center formation (GO:0002634) | 2.12633399 |
| 142 | response to interleukin-15 (GO:0070672) | 2.12213869 |
| 143 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.11978677 |
| 144 | histone H3-K9 modification (GO:0061647) | 2.11854244 |
| 145 | histone lysine methylation (GO:0034968) | 2.11080945 |
| 146 | B cell homeostasis (GO:0001782) | 2.10016286 |
| 147 | positive regulation of interferon-beta production (GO:0032728) | 2.09334376 |
| 148 | interkinetic nuclear migration (GO:0022027) | 2.08868094 |
| 149 | modulation by virus of host process (GO:0019054) | 2.08441506 |
| 150 | mesenchymal cell differentiation (GO:0048762) | 2.07932847 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.58617892 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.11566658 |
| 3 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.90358438 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.88286391 |
| 5 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.88262578 |
| 6 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.76297259 |
| 7 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.49519079 |
| 8 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.41543881 |
| 9 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.34403346 |
| 10 | GATA1_22025678_ChIP-Seq_K562_Human | 2.31694750 |
| 11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.31430197 |
| 12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.30211408 |
| 13 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.29520753 |
| 14 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.23842628 |
| 15 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.09420056 |
| 16 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.08190985 |
| 17 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.06994799 |
| 18 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.01925682 |
| 19 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.95876862 |
| 20 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.94426808 |
| 21 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.87397816 |
| 22 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.82019769 |
| 23 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.74585983 |
| 24 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.72811610 |
| 25 | FUS_26573619_Chip-Seq_HEK293_Human | 1.71055340 |
| 26 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.70483160 |
| 27 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.65087820 |
| 28 | EWS_26573619_Chip-Seq_HEK293_Human | 1.64548066 |
| 29 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.62757669 |
| 30 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.62020734 |
| 31 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.60119616 |
| 32 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.58623737 |
| 33 | MYB_26560356_Chip-Seq_TH2_Human | 1.58581276 |
| 34 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.58179586 |
| 35 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.56185359 |
| 36 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.51301928 |
| 37 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.49682543 |
| 38 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.48892486 |
| 39 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.48583353 |
| 40 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.47135051 |
| 41 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.46761268 |
| 42 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.46421149 |
| 43 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.46351848 |
| 44 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.44845796 |
| 45 | TP53_16413492_ChIP-PET_HCT116_Human | 1.44821124 |
| 46 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.44540925 |
| 47 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.44448703 |
| 48 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.44202855 |
| 49 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.44019806 |
| 50 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.43295952 |
| 51 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.42901972 |
| 52 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.42699226 |
| 53 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.40832029 |
| 54 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.40586334 |
| 55 | GATA3_26560356_Chip-Seq_TH2_Human | 1.39016962 |
| 56 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.38536644 |
| 57 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.37245035 |
| 58 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.35810936 |
| 59 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.35304930 |
| 60 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.35211856 |
| 61 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.35211856 |
| 62 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.33706141 |
| 63 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.32206559 |
| 64 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.30218091 |
| 65 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.29934710 |
| 66 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.29301044 |
| 67 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.27249780 |
| 68 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.26299621 |
| 69 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.26193933 |
| 70 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.26185729 |
| 71 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.26006943 |
| 72 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.25797675 |
| 73 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.24975003 |
| 74 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.24159491 |
| 75 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.22358679 |
| 76 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.21104028 |
| 77 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.20220382 |
| 78 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.19741998 |
| 79 | STAT3_23295773_ChIP-Seq_U87_Human | 1.18855629 |
| 80 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.17642919 |
| 81 | VDR_22108803_ChIP-Seq_LS180_Human | 1.17112419 |
| 82 | * MYB_26560356_Chip-Seq_TH1_Human | 1.16527129 |
| 83 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.16164938 |
| 84 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.16085646 |
| 85 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.15439988 |
| 86 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.15004994 |
| 87 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.14558205 |
| 88 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.14275071 |
| 89 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.13908532 |
| 90 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.13835888 |
| 91 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.12554725 |
| 92 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.11160818 |
| 93 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.10740171 |
| 94 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.10617135 |
| 95 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.10514473 |
| 96 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.10363394 |
| 97 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.10003313 |
| 98 | * CBP_20019798_ChIP-Seq_JUKART_Human | 1.09503120 |
| 99 | * IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.09503120 |
| 100 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.08980069 |
| 101 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.08776292 |
| 102 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.08507907 |
| 103 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.07469002 |
| 104 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.06112914 |
| 105 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.05975012 |
| 106 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.05911549 |
| 107 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.05894518 |
| 108 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.04144125 |
| 109 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.03776761 |
| 110 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.03703169 |
| 111 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.03380191 |
| 112 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.03138859 |
| 113 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.02397652 |
| 114 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.02124810 |
| 115 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.00993463 |
| 116 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.00758820 |
| 117 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.00310170 |
| 118 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.99676727 |
| 119 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.99418167 |
| 120 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98677212 |
| 121 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.98008939 |
| 122 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.97775239 |
| 123 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.97163112 |
| 124 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.96920865 |
| 125 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.96417624 |
| 126 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.96026805 |
| 127 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.95976079 |
| 128 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.95251347 |
| 129 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.95022727 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 3.86593876 |
| 2 | MP0002009_preneoplasia | 2.97815215 |
| 3 | MP0003303_peritoneal_inflammation | 2.70446883 |
| 4 | MP0002166_altered_tumor_susceptibility | 2.68965700 |
| 5 | MP0005409_darkened_coat_color | 2.64137007 |
| 6 | MP0002006_tumorigenesis | 2.56567868 |
| 7 | MP0001188_hyperpigmentation | 2.53745919 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.49393958 |
| 9 | MP0003787_abnormal_imprinting | 2.35769658 |
| 10 | MP0005671_abnormal_response_to | 2.28984570 |
| 11 | MP0000015_abnormal_ear_pigmentation | 2.04761989 |
| 12 | MP0003724_increased_susceptibility_to | 2.02507107 |
| 13 | MP0005174_abnormal_tail_pigmentation | 1.98433154 |
| 14 | MP0008057_abnormal_DNA_replication | 1.93984337 |
| 15 | MP0001790_abnormal_immune_system | 1.93517215 |
| 16 | MP0005387_immune_system_phenotype | 1.93517215 |
| 17 | MP0006292_abnormal_olfactory_placode | 1.87756602 |
| 18 | MP0002277_abnormal_respiratory_mucosa | 1.80357640 |
| 19 | MP0003763_abnormal_thymus_physiology | 1.80307523 |
| 20 | MP0001800_abnormal_humoral_immune | 1.71091996 |
| 21 | MP0003656_abnormal_erythrocyte_physiolo | 1.70595658 |
| 22 | MP0005000_abnormal_immune_tolerance | 1.64350928 |
| 23 | MP0009785_altered_susceptibility_to | 1.61724481 |
| 24 | MP0003195_calcinosis | 1.59797963 |
| 25 | MP0003866_abnormal_defecation | 1.56858797 |
| 26 | MP0002452_abnormal_antigen_presenting | 1.51893773 |
| 27 | MP0002148_abnormal_hypersensitivity_rea | 1.50661521 |
| 28 | MP0001845_abnormal_inflammatory_respons | 1.50279566 |
| 29 | MP0002163_abnormal_gland_morphology | 1.49876462 |
| 30 | MP0003121_genomic_imprinting | 1.49363891 |
| 31 | MP0009764_decreased_sensitivity_to | 1.47111043 |
| 32 | MP0002723_abnormal_immune_serum | 1.47069225 |
| 33 | MP0005076_abnormal_cell_differentiation | 1.42898864 |
| 34 | MP0002132_abnormal_respiratory_system | 1.42788771 |
| 35 | MP0000465_gastrointestinal_hemorrhage | 1.41800802 |
| 36 | MP0001819_abnormal_immune_cell | 1.41198719 |
| 37 | MP0002420_abnormal_adaptive_immunity | 1.41065524 |
| 38 | MP0004883_abnormal_blood_vessel | 1.40326883 |
| 39 | MP0004510_myositis | 1.36067484 |
| 40 | MP0000383_abnormal_hair_follicle | 1.34625343 |
| 41 | MP0000685_abnormal_immune_system | 1.33358863 |
| 42 | MP0000703_abnormal_thymus_morphology | 1.32726386 |
| 43 | MP0003646_muscle_fatigue | 1.31922883 |
| 44 | MP0003183_abnormal_peptide_metabolism | 1.28941365 |
| 45 | MP0002398_abnormal_bone_marrow | 1.28720301 |
| 46 | MP0004808_abnormal_hematopoietic_stem | 1.26131711 |
| 47 | MP0001879_abnormal_lymphatic_vessel | 1.25961907 |
| 48 | MP0002095_abnormal_skin_pigmentation | 1.25085405 |
| 49 | MP0002332_abnormal_exercise_endurance | 1.23690396 |
| 50 | MP0004381_abnormal_hair_follicle | 1.23173962 |
| 51 | MP0003941_abnormal_skin_development | 1.21831371 |
| 52 | MP0005075_abnormal_melanosome_morpholog | 1.21084915 |
| 53 | MP0002419_abnormal_innate_immunity | 1.20550086 |
| 54 | MP0008877_abnormal_DNA_methylation | 1.19324402 |
| 55 | MP0003045_fibrosis | 1.17626900 |
| 56 | MP0001346_abnormal_lacrimal_gland | 1.17556318 |
| 57 | MP0006082_CNS_inflammation | 1.16033121 |
| 58 | MP0009278_abnormal_bone_marrow | 1.15801603 |
| 59 | MP0001533_abnormal_skeleton_physiology | 1.15526997 |
| 60 | MP0005025_abnormal_response_to | 1.14111589 |
| 61 | MP0000716_abnormal_immune_system | 1.13321738 |
| 62 | MP0005379_endocrine/exocrine_gland_phen | 1.12246922 |
| 63 | MP0004130_abnormal_muscle_cell | 1.11087824 |
| 64 | MP0000372_irregular_coat_pigmentation | 1.11056250 |
| 65 | MP0002396_abnormal_hematopoietic_system | 1.10353489 |
| 66 | MP0003252_abnormal_bile_duct | 1.09797608 |
| 67 | MP0002877_abnormal_melanocyte_morpholog | 1.09563436 |
| 68 | MP0005464_abnormal_platelet_physiology | 1.09526574 |
| 69 | MP0002405_respiratory_system_inflammati | 1.09104467 |
| 70 | MP0006072_abnormal_retinal_apoptosis | 1.07037758 |
| 71 | MP0008469_abnormal_protein_level | 1.05164428 |
| 72 | MP0005164_abnormal_response_to | 1.04561005 |
| 73 | MP0006054_spinal_hemorrhage | 1.02190726 |
| 74 | MP0005248_abnormal_Harderian_gland | 1.00014823 |
| 75 | MP0000566_synostosis | 0.99800474 |
| 76 | MP0002102_abnormal_ear_morphology | 0.99709692 |
| 77 | MP0001851_eye_inflammation | 0.99622613 |
| 78 | MP0001873_stomach_inflammation | 0.99591194 |
| 79 | MP0008058_abnormal_DNA_repair | 0.99462413 |
| 80 | MP0003136_yellow_coat_color | 0.98305741 |
| 81 | MP0002177_abnormal_outer_ear | 0.97901338 |
| 82 | MP0005645_abnormal_hypothalamus_physiol | 0.97780014 |
| 83 | MP0004947_skin_inflammation | 0.97297328 |
| 84 | MP0004484_altered_response_of | 0.96862123 |
| 85 | MP0002933_joint_inflammation | 0.96806400 |
| 86 | MP0005171_absent_coat_pigmentation | 0.96674217 |
| 87 | MP0003828_pulmonary_edema | 0.95469889 |
| 88 | MP0003890_abnormal_embryonic-extraembry | 0.95241094 |
| 89 | MP0001186_pigmentation_phenotype | 0.95114292 |
| 90 | MP0003172_abnormal_lysosome_physiology | 0.94861294 |
| 91 | MP0010094_abnormal_chromosome_stability | 0.93144663 |
| 92 | MP0003448_altered_tumor_morphology | 0.92935853 |
| 93 | MP0003436_decreased_susceptibility_to | 0.92104073 |
| 94 | MP0002928_abnormal_bile_duct | 0.90947302 |
| 95 | MP0002998_abnormal_bone_remodeling | 0.90776687 |
| 96 | MP0002938_white_spotting | 0.90725431 |
| 97 | MP0002722_abnormal_immune_system | 0.89760319 |
| 98 | MP0003950_abnormal_plasma_membrane | 0.88897885 |
| 99 | MP0010678_abnormal_skin_adnexa | 0.88355110 |
| 100 | MP0003221_abnormal_cardiomyocyte_apopto | 0.87420194 |
| 101 | MP0005310_abnormal_salivary_gland | 0.86838391 |
| 102 | MP0005397_hematopoietic_system_phenotyp | 0.84594315 |
| 103 | MP0001545_abnormal_hematopoietic_system | 0.84594315 |
| 104 | MP0002075_abnormal_coat/hair_pigmentati | 0.83277641 |
| 105 | MP0010155_abnormal_intestine_physiology | 0.82494225 |
| 106 | MP0003937_abnormal_limbs/digits/tail_de | 0.82104490 |
| 107 | MP0000689_abnormal_spleen_morphology | 0.80921638 |
| 108 | MP0000613_abnormal_salivary_gland | 0.78834200 |
| 109 | MP0010386_abnormal_urinary_bladder | 0.78814216 |
| 110 | MP0001299_abnormal_eye_distance/ | 0.78083321 |
| 111 | MP0004043_abnormal_pH_regulation | 0.77753466 |
| 112 | MP0010307_abnormal_tumor_latency | 0.77096203 |
| 113 | MP0002429_abnormal_blood_cell | 0.76850395 |
| 114 | MP0002693_abnormal_pancreas_physiology | 0.76733861 |
| 115 | MP0002138_abnormal_hepatobiliary_system | 0.75551915 |
| 116 | MP0003300_gastrointestinal_ulcer | 0.75254333 |
| 117 | MP0000427_abnormal_hair_cycle | 0.75243816 |
| 118 | MP0005266_abnormal_metabolism | 0.74462556 |
| 119 | MP0003935_abnormal_craniofacial_develop | 0.73977537 |
| 120 | MP0003690_abnormal_glial_cell | 0.73325768 |
| 121 | MP0008789_abnormal_olfactory_epithelium | 0.73211489 |
| 122 | MP0000432_abnormal_head_morphology | 0.73120332 |
| 123 | MP0001501_abnormal_sleep_pattern | 0.73117739 |
| 124 | MP0008007_abnormal_cellular_replicative | 0.72839619 |
| 125 | MP0004142_abnormal_muscle_tone | 0.72772316 |
| 126 | MP0009333_abnormal_splenocyte_physiolog | 0.70824988 |
| 127 | MP0008004_abnormal_stomach_pH | 0.70133911 |
| 128 | MP0003091_abnormal_cell_migration | 0.70018352 |
| 129 | MP0000516_abnormal_urinary_system | 0.69974916 |
| 130 | MP0005367_renal/urinary_system_phenotyp | 0.69974916 |
| 131 | MP0001919_abnormal_reproductive_system | 0.69763795 |
| 132 | MP0008961_abnormal_basal_metabolism | 0.68148426 |
| 133 | MP0000249_abnormal_blood_vessel | 0.67232700 |
| 134 | MP0009763_increased_sensitivity_to | 0.67144823 |
| 135 | MP0003122_maternal_imprinting | 0.66888333 |
| 136 | MP0003755_abnormal_palate_morphology | 0.66882347 |
| 137 | MP0005253_abnormal_eye_physiology | 0.65665436 |
| 138 | MP0000627_abnormal_mammary_gland | 0.65398364 |
| 139 | MP0005376_homeostasis/metabolism_phenot | 0.64953795 |
| 140 | MP0001663_abnormal_digestive_system | 0.64456278 |
| 141 | MP0000371_diluted_coat_color | 0.63711020 |
| 142 | MP0001293_anophthalmia | 0.62797320 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.92440222 |
| 2 | Gastrointestinal infarctions (HP:0005244) | 3.85192786 |
| 3 | Abnormality of the fingertips (HP:0001211) | 3.81431868 |
| 4 | Stomatitis (HP:0010280) | 3.73971449 |
| 5 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.26241243 |
| 6 | Abnormality of the nasal septum (HP:0000419) | 3.24383434 |
| 7 | Volvulus (HP:0002580) | 3.20094582 |
| 8 | Recurrent bronchitis (HP:0002837) | 3.14337953 |
| 9 | Chromsome breakage (HP:0040012) | 3.14228739 |
| 10 | Papillary thyroid carcinoma (HP:0002895) | 3.12974282 |
| 11 | Abnormality of T cell number (HP:0011839) | 3.09487502 |
| 12 | Recurrent skin infections (HP:0001581) | 3.09084107 |
| 13 | T lymphocytopenia (HP:0005403) | 3.02842227 |
| 14 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.99173908 |
| 15 | Autoimmune hemolytic anemia (HP:0001890) | 2.96107777 |
| 16 | Prostate neoplasm (HP:0100787) | 2.95986237 |
| 17 | Retrobulbar optic neuritis (HP:0100654) | 2.95244954 |
| 18 | Optic neuritis (HP:0100653) | 2.95244954 |
| 19 | Spontaneous hematomas (HP:0007420) | 2.93597472 |
| 20 | Hemoptysis (HP:0002105) | 2.93063837 |
| 21 | Encephalitis (HP:0002383) | 2.88727533 |
| 22 | Thyroiditis (HP:0100646) | 2.85909261 |
| 23 | Gingival bleeding (HP:0000225) | 2.78869536 |
| 24 | Abnormality of incisor morphology (HP:0011063) | 2.77192100 |
| 25 | Lip pit (HP:0100267) | 2.70023042 |
| 26 | Genetic anticipation (HP:0003743) | 2.69049929 |
| 27 | Fair hair (HP:0002286) | 2.64943718 |
| 28 | Ectopic kidney (HP:0000086) | 2.61821662 |
| 29 | Peritonitis (HP:0002586) | 2.58300204 |
| 30 | Hematochezia (HP:0002573) | 2.55496950 |
| 31 | Chest pain (HP:0100749) | 2.54086611 |
| 32 | Recurrent viral infections (HP:0004429) | 2.53494393 |
| 33 | Stomach cancer (HP:0012126) | 2.52486329 |
| 34 | Arterial thrombosis (HP:0004420) | 2.50701238 |
| 35 | Generalized hypopigmentation of hair (HP:0011358) | 2.44353894 |
| 36 | Orchitis (HP:0100796) | 2.34609068 |
| 37 | Eosinophilia (HP:0001880) | 2.34495014 |
| 38 | Abnormal hair whorl (HP:0010721) | 2.34121326 |
| 39 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.33657437 |
| 40 | Subacute progressive viral hepatitis (HP:0006572) | 2.27956251 |
| 41 | Recurrent fungal infections (HP:0002841) | 2.24060473 |
| 42 | Abnormality of B cell number (HP:0010975) | 2.23770440 |
| 43 | B lymphocytopenia (HP:0010976) | 2.23770440 |
| 44 | Deep philtrum (HP:0002002) | 2.22274439 |
| 45 | Abnormality of macrophages (HP:0004311) | 2.22133930 |
| 46 | Acute hepatic failure (HP:0006554) | 2.19865264 |
| 47 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.19460168 |
| 48 | Long eyelashes (HP:0000527) | 2.19094093 |
| 49 | Abnormality of the renal cortex (HP:0011035) | 2.18837864 |
| 50 | Severe combined immunodeficiency (HP:0004430) | 2.18786306 |
| 51 | Autoimmune thrombocytopenia (HP:0001973) | 2.14677281 |
| 52 | Submucous cleft hard palate (HP:0000176) | 2.13771513 |
| 53 | Papilledema (HP:0001085) | 2.10552671 |
| 54 | Gangrene (HP:0100758) | 2.08901832 |
| 55 | Hyperventilation (HP:0002883) | 2.08186297 |
| 56 | Thyroid carcinoma (HP:0002890) | 2.07764924 |
| 57 | Alveolar cell carcinoma (HP:0006519) | 2.07552705 |
| 58 | Abnormality of T cell physiology (HP:0011840) | 2.07540083 |
| 59 | Panhypogammaglobulinemia (HP:0003139) | 2.06700556 |
| 60 | Abnormality of the incisor (HP:0000676) | 2.06573101 |
| 61 | Joint swelling (HP:0001386) | 2.05414760 |
| 62 | Recurrent abscess formation (HP:0002722) | 2.05211507 |
| 63 | Gaze-evoked nystagmus (HP:0000640) | 2.02839902 |
| 64 | Prolonged bleeding time (HP:0003010) | 2.02446415 |
| 65 | Aplasia cutis congenita (HP:0001057) | 2.00993313 |
| 66 | Chronic diarrhea (HP:0002028) | 1.98880035 |
| 67 | Inflammation of the large intestine (HP:0002037) | 1.98647153 |
| 68 | Absent frontal sinuses (HP:0002688) | 1.98591476 |
| 69 | Recurrent cutaneous fungal infections (HP:0011370) | 1.98388582 |
| 70 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.98388582 |
| 71 | Pulmonary embolism (HP:0002204) | 1.97667339 |
| 72 | Myositis (HP:0100614) | 1.94840568 |
| 73 | Increased IgM level (HP:0003496) | 1.94815135 |
| 74 | Viral hepatitis (HP:0006562) | 1.92219462 |
| 75 | Colitis (HP:0002583) | 1.91509687 |
| 76 | Abnormality of the pleura (HP:0002103) | 1.91108326 |
| 77 | Granulocytopenia (HP:0001913) | 1.90450031 |
| 78 | Abnormality of eosinophils (HP:0001879) | 1.89920269 |
| 79 | Mediastinal lymphadenopathy (HP:0100721) | 1.89721315 |
| 80 | Anorexia (HP:0002039) | 1.89653982 |
| 81 | Anal stenosis (HP:0002025) | 1.89625191 |
| 82 | Short 4th metacarpal (HP:0010044) | 1.88927984 |
| 83 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.88927984 |
| 84 | Widely spaced teeth (HP:0000687) | 1.87753788 |
| 85 | Pustule (HP:0200039) | 1.87539778 |
| 86 | Vasculitis (HP:0002633) | 1.86074738 |
| 87 | Progressive cerebellar ataxia (HP:0002073) | 1.85910942 |
| 88 | Poikilocytosis (HP:0004447) | 1.84467851 |
| 89 | Abnormality of the renal collecting system (HP:0004742) | 1.82857891 |
| 90 | Eczematoid dermatitis (HP:0000976) | 1.81772625 |
| 91 | Narrow palate (HP:0000189) | 1.81672433 |
| 92 | Epistaxis (HP:0000421) | 1.81310532 |
| 93 | Protruding tongue (HP:0010808) | 1.80437554 |
| 94 | Abnormality of the endocardium (HP:0004306) | 1.80012677 |
| 95 | Duplicated collecting system (HP:0000081) | 1.79439079 |
| 96 | Microvesicular hepatic steatosis (HP:0001414) | 1.78839322 |
| 97 | Chronic hepatic failure (HP:0100626) | 1.78808044 |
| 98 | Trigonocephaly (HP:0000243) | 1.78701755 |
| 99 | Acute myeloid leukemia (HP:0004808) | 1.78560899 |
| 100 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.78033984 |
| 101 | Cupped ear (HP:0000378) | 1.78009085 |
| 102 | Abnormality of DNA repair (HP:0003254) | 1.78005185 |
| 103 | Hypoplasia of the thymus (HP:0000778) | 1.77636686 |
| 104 | Albinism (HP:0001022) | 1.76748653 |
| 105 | Abnormality of secondary sexual hair (HP:0009888) | 1.74484437 |
| 106 | Abnormality of the axillary hair (HP:0100134) | 1.74484437 |
| 107 | Renal cortical cysts (HP:0000803) | 1.74425405 |
| 108 | Keratitis (HP:0000491) | 1.74079375 |
| 109 | Conical tooth (HP:0000698) | 1.73889185 |
| 110 | Clubbing of toes (HP:0100760) | 1.73011901 |
| 111 | Chronic otitis media (HP:0000389) | 1.72443529 |
| 112 | Bronchitis (HP:0012387) | 1.72374215 |
| 113 | Spinal cord lesions (HP:0100561) | 1.72349509 |
| 114 | Syringomyelia (HP:0003396) | 1.72349509 |
| 115 | Meningitis (HP:0001287) | 1.72079142 |
| 116 | Absent eyebrow (HP:0002223) | 1.72023055 |
| 117 | Urticaria (HP:0001025) | 1.69861551 |
| 118 | Keratoconjunctivitis sicca (HP:0001097) | 1.69140318 |
| 119 | Midline defect of the nose (HP:0004122) | 1.68681683 |
| 120 | Anhidrosis (HP:0000970) | 1.67113666 |
| 121 | IgG deficiency (HP:0004315) | 1.66881027 |
| 122 | Leukocytosis (HP:0001974) | 1.65502937 |
| 123 | Gastrointestinal inflammation (HP:0004386) | 1.64853910 |
| 124 | Truncal obesity (HP:0001956) | 1.63727669 |
| 125 | Hyperkalemia (HP:0002153) | 1.62959222 |
| 126 | Pulmonary infiltrates (HP:0002113) | 1.62926908 |
| 127 | Hypochromic microcytic anemia (HP:0004840) | 1.62524897 |
| 128 | Increased IgE level (HP:0003212) | 1.62215883 |
| 129 | Febrile seizures (HP:0002373) | 1.62036091 |
| 130 | Supernumerary ribs (HP:0005815) | 1.61019147 |
| 131 | Recurrent pneumonia (HP:0006532) | 1.60516473 |
| 132 | IgA deficiency (HP:0002720) | 1.57609496 |
| 133 | Abnormality of T cells (HP:0002843) | 1.57486605 |
| 134 | Abnormality of the parietal bone (HP:0002696) | 1.56716827 |
| 135 | Recurrent bacterial skin infections (HP:0005406) | 1.56023597 |
| 136 | Congenital stationary night blindness (HP:0007642) | 1.54913133 |
| 137 | Agammaglobulinemia (HP:0004432) | 1.53900559 |
| 138 | Lymphopenia (HP:0001888) | 1.53760967 |
| 139 | Ectropion (HP:0000656) | 1.53604241 |
| 140 | Chronic sinusitis (HP:0011109) | 1.53553899 |
| 141 | Chronic obstructive pulmonary disease (HP:0006510) | 1.53455619 |
| 142 | Obstructive lung disease (HP:0006536) | 1.53455619 |
| 143 | Urethral obstruction (HP:0000796) | 1.53422975 |
| 144 | Periodontitis (HP:0000704) | 1.53195512 |
| 145 | Abnormality of chromosome stability (HP:0003220) | 1.52900744 |
| 146 | Abnormality of the prostate (HP:0008775) | 1.52647240 |
| 147 | Gingivitis (HP:0000230) | 1.51455543 |
| 148 | Abnormality of the columella (HP:0009929) | 1.51137811 |
| 149 | Hypoproteinemia (HP:0003075) | 1.51001449 |
| 150 | Supernumerary bones of the axial skeleton (HP:0009144) | 1.50966419 |
| 151 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.49597346 |
| 152 | Combined immunodeficiency (HP:0005387) | 1.48300332 |
| 153 | Abnormality of the frontal sinuses (HP:0002687) | 1.48200232 |
| 154 | Keratoconjunctivitis (HP:0001096) | 1.47922497 |
| 155 | Obsessive-compulsive behavior (HP:0000722) | 1.47239010 |
| 156 | Pulmonary artery stenosis (HP:0004415) | 1.45594658 |
| 157 | Thick nail (HP:0001805) | 1.45497279 |
| 158 | Increased number of teeth (HP:0011069) | 1.44888012 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 3.71658875 |
| 2 | MAP3K14 | 3.13558751 |
| 3 | CDK12 | 2.77300895 |
| 4 | ZAK | 2.50042706 |
| 5 | ACVR1B | 2.42391083 |
| 6 | CAMKK2 | 2.33120785 |
| 7 | YES1 | 2.28012807 |
| 8 | BRD4 | 2.27710454 |
| 9 | IRAK4 | 2.24305930 |
| 10 | RIPK4 | 2.22831581 |
| 11 | NUAK1 | 2.17411924 |
| 12 | BLK | 2.13514412 |
| 13 | IRAK3 | 2.02875857 |
| 14 | CASK | 1.95939158 |
| 15 | CAMK1D | 1.92797223 |
| 16 | MKNK2 | 1.87417964 |
| 17 | IKBKE | 1.85388634 |
| 18 | CAMK1G | 1.84034544 |
| 19 | TYK2 | 1.78503653 |
| 20 | INSRR | 1.70893090 |
| 21 | JAK1 | 1.70645883 |
| 22 | FRK | 1.70355852 |
| 23 | PIK3CG | 1.66663977 |
| 24 | EIF2AK2 | 1.62033175 |
| 25 | FGFR3 | 1.51879323 |
| 26 | NEK6 | 1.48196033 |
| 27 | JAK3 | 1.46418715 |
| 28 | BTK | 1.45901775 |
| 29 | AKT3 | 1.45622268 |
| 30 | LATS1 | 1.42911462 |
| 31 | SGK2 | 1.36099070 |
| 32 | TNIK | 1.35710313 |
| 33 | EPHA3 | 1.34528710 |
| 34 | MAP3K13 | 1.28768638 |
| 35 | IKBKB | 1.24467447 |
| 36 | GRK6 | 1.23909726 |
| 37 | BMPR1B | 1.22566031 |
| 38 | JAK2 | 1.20110022 |
| 39 | TEC | 1.19539098 |
| 40 | CDK3 | 1.18672010 |
| 41 | CHUK | 1.15908177 |
| 42 | MAP3K2 | 1.15729023 |
| 43 | MAP4K1 | 1.13829768 |
| 44 | FGFR4 | 1.12775744 |
| 45 | NLK | 1.09716603 |
| 46 | CDK9 | 1.09005310 |
| 47 | ZAP70 | 1.06303034 |
| 48 | FGR | 1.03120460 |
| 49 | MKNK1 | 1.02997655 |
| 50 | FES | 1.02176120 |
| 51 | IRAK1 | 1.01644526 |
| 52 | SGK3 | 0.99486098 |
| 53 | HCK | 0.95707470 |
| 54 | ITK | 0.94417388 |
| 55 | PDGFRB | 0.93657898 |
| 56 | SRPK1 | 0.92648130 |
| 57 | MARK3 | 0.90633767 |
| 58 | LCK | 0.89449489 |
| 59 | MAP2K3 | 0.87796118 |
| 60 | MATK | 0.87046869 |
| 61 | PTK2B | 0.86832997 |
| 62 | PRKCQ | 0.86785622 |
| 63 | PAK3 | 0.86719358 |
| 64 | ERBB3 | 0.86051010 |
| 65 | GRK1 | 0.85387377 |
| 66 | BMPR2 | 0.84135719 |
| 67 | ATR | 0.83878942 |
| 68 | WNK1 | 0.82989428 |
| 69 | STK3 | 0.82158100 |
| 70 | MAP3K7 | 0.81470351 |
| 71 | MAPK7 | 0.79053139 |
| 72 | STK4 | 0.78260886 |
| 73 | MAP3K4 | 0.77122860 |
| 74 | SIK3 | 0.76716895 |
| 75 | GRK7 | 0.76140290 |
| 76 | ATM | 0.75059891 |
| 77 | SYK | 0.72498220 |
| 78 | SIK2 | 0.71791731 |
| 79 | TRPM7 | 0.70501527 |
| 80 | CDK6 | 0.69890214 |
| 81 | PIK3CA | 0.67298999 |
| 82 | CSNK1A1L | 0.67052435 |
| 83 | PLK4 | 0.67029903 |
| 84 | IRAK2 | 0.65936141 |
| 85 | SGK1 | 0.65846664 |
| 86 | PKN1 | 0.65644804 |
| 87 | MAPK13 | 0.64577082 |
| 88 | STK11 | 0.63656110 |
| 89 | BCR | 0.62985150 |
| 90 | TBK1 | 0.62736560 |
| 91 | MELK | 0.62246775 |
| 92 | MARK2 | 0.61522207 |
| 93 | PRKAA2 | 0.61174602 |
| 94 | KIT | 0.59625211 |
| 95 | CLK1 | 0.58409270 |
| 96 | MAP4K2 | 0.58132723 |
| 97 | RPS6KB1 | 0.58046067 |
| 98 | CSF1R | 0.57278657 |
| 99 | CAMKK1 | 0.57251922 |
| 100 | EPHB1 | 0.56312826 |
| 101 | TAOK3 | 0.56208339 |
| 102 | FGFR2 | 0.56089792 |
| 103 | BRSK2 | 0.54348490 |
| 104 | RPS6KA5 | 0.54228622 |
| 105 | TNK2 | 0.53988352 |
| 106 | PDK1 | 0.50845177 |
| 107 | CSK | 0.50618434 |
| 108 | PIM1 | 0.49226461 |
| 109 | ADRBK1 | 0.48997285 |
| 110 | OBSCN | 0.48727784 |
| 111 | TLK1 | 0.47803267 |
| 112 | OXSR1 | 0.47249941 |
| 113 | PRPF4B | 0.46894978 |
| 114 | RET | 0.45898859 |
| 115 | ADRBK2 | 0.45695466 |
| 116 | LYN | 0.45551386 |
| 117 | DMPK | 0.44948745 |
| 118 | EIF2AK3 | 0.44777177 |
| 119 | MAPK14 | 0.44018064 |
| 120 | HIPK2 | 0.43955285 |
| 121 | ERBB2 | 0.43621001 |
| 122 | MST4 | 0.43309631 |
| 123 | STK39 | 0.43048846 |
| 124 | NEK9 | 0.42914379 |
| 125 | EGFR | 0.42860231 |
| 126 | ABL1 | 0.42590933 |
| 127 | RPS6KA4 | 0.42066891 |
| 128 | MAP2K6 | 0.41818545 |
| 129 | RPS6KB2 | 0.41380299 |
| 130 | SGK494 | 0.40803341 |
| 131 | SGK223 | 0.40803341 |
| 132 | TGFBR2 | 0.39800603 |
| 133 | VRK1 | 0.39703124 |
| 134 | DYRK1A | 0.39422573 |
| 135 | PRKCE | 0.36728310 |
| 136 | CAMK4 | 0.36575133 |
| 137 | RIPK1 | 0.35399599 |
| 138 | PBK | 0.35341179 |
| 139 | MAP3K6 | 0.35024034 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.14474307 |
| 2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.11229503 |
| 3 | Measles_Homo sapiens_hsa05162 | 1.89964759 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 1.81164622 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.79262479 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.77205576 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.73056263 |
| 8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.66271568 |
| 9 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.59980130 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.57856224 |
| 11 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.52533800 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 1.52035756 |
| 13 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.46378648 |
| 14 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.46096265 |
| 15 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.43996361 |
| 16 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.39727294 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.38531399 |
| 18 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.36992266 |
| 19 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.33147537 |
| 20 | Influenza A_Homo sapiens_hsa05164 | 1.29193690 |
| 21 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.26495968 |
| 22 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.22181598 |
| 23 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.20379480 |
| 24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.20100811 |
| 25 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.15233219 |
| 26 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.13914114 |
| 27 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.11356804 |
| 28 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.09593340 |
| 29 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.08700766 |
| 30 | Phototransduction_Homo sapiens_hsa04744 | 1.07578978 |
| 31 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.06732363 |
| 32 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.05910493 |
| 33 | Hepatitis B_Homo sapiens_hsa05161 | 1.04927728 |
| 34 | Prostate cancer_Homo sapiens_hsa05215 | 1.00870414 |
| 35 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.00164879 |
| 36 | Malaria_Homo sapiens_hsa05144 | 0.98679198 |
| 37 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.97880329 |
| 38 | Hepatitis C_Homo sapiens_hsa05160 | 0.97813488 |
| 39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.97135152 |
| 40 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.94189179 |
| 41 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.91949643 |
| 42 | ABC transporters_Homo sapiens_hsa02010 | 0.91762417 |
| 43 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.90746544 |
| 44 | Tuberculosis_Homo sapiens_hsa05152 | 0.90283023 |
| 45 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.89614323 |
| 46 | Asthma_Homo sapiens_hsa05310 | 0.89137478 |
| 47 | Circadian rhythm_Homo sapiens_hsa04710 | 0.88924707 |
| 48 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.88156050 |
| 49 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.88094529 |
| 50 | Viral myocarditis_Homo sapiens_hsa05416 | 0.87885967 |
| 51 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.85144430 |
| 52 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.85014587 |
| 53 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.83002649 |
| 54 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.82554303 |
| 55 | HTLV-I infection_Homo sapiens_hsa05166 | 0.79844656 |
| 56 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.79078020 |
| 57 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.78914265 |
| 58 | Nicotine addiction_Homo sapiens_hsa05033 | 0.77632117 |
| 59 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.77423926 |
| 60 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.76372292 |
| 61 | Apoptosis_Homo sapiens_hsa04210 | 0.75883615 |
| 62 | Adherens junction_Homo sapiens_hsa04520 | 0.74317723 |
| 63 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.74026161 |
| 64 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.73740096 |
| 65 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.73650448 |
| 66 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.72575122 |
| 67 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.72430747 |
| 68 | Pertussis_Homo sapiens_hsa05133 | 0.72421638 |
| 69 | Colorectal cancer_Homo sapiens_hsa05210 | 0.71762321 |
| 70 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.71210814 |
| 71 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.70829110 |
| 72 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.69776903 |
| 73 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.69057854 |
| 74 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.68986996 |
| 75 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.68418802 |
| 76 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.67017740 |
| 77 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.66629894 |
| 78 | Insulin resistance_Homo sapiens_hsa04931 | 0.66137360 |
| 79 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.65907607 |
| 80 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.65549825 |
| 81 | Pathways in cancer_Homo sapiens_hsa05200 | 0.64674734 |
| 82 | Axon guidance_Homo sapiens_hsa04360 | 0.64524250 |
| 83 | Morphine addiction_Homo sapiens_hsa05032 | 0.63935960 |
| 84 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.63224529 |
| 85 | Endometrial cancer_Homo sapiens_hsa05213 | 0.63024663 |
| 86 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.61525598 |
| 87 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.61272505 |
| 88 | Salmonella infection_Homo sapiens_hsa05132 | 0.61095813 |
| 89 | Melanoma_Homo sapiens_hsa05218 | 0.60288706 |
| 90 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.60212642 |
| 91 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.59748011 |
| 92 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.59677930 |
| 93 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.59525432 |
| 94 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.59455951 |
| 95 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.59409647 |
| 96 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.59215906 |
| 97 | Platelet activation_Homo sapiens_hsa04611 | 0.59051264 |
| 98 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.58903915 |
| 99 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.58832277 |
| 100 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.58446402 |
| 101 | Renin secretion_Homo sapiens_hsa04924 | 0.58265623 |
| 102 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.57595733 |
| 103 | Homologous recombination_Homo sapiens_hsa03440 | 0.57170598 |
| 104 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.57114402 |
| 105 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.57027140 |
| 106 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.55254108 |
| 107 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.55189969 |
| 108 | Taste transduction_Homo sapiens_hsa04742 | 0.54868532 |
| 109 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.54615870 |
| 110 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.54378750 |
| 111 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.54334215 |
| 112 | Legionellosis_Homo sapiens_hsa05134 | 0.54248989 |
| 113 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.53997555 |
| 114 | * RNA degradation_Homo sapiens_hsa03018 | 0.53946935 |
| 115 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.53524386 |
| 116 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.53160360 |
| 117 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.52907660 |
| 118 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.51843916 |
| 119 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.51295352 |
| 120 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.49185996 |
| 121 | Phagosome_Homo sapiens_hsa04145 | 0.47152156 |
| 122 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.45118715 |
| 123 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.44048493 |
| 124 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.43710429 |
| 125 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.42780356 |
| 126 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.41745665 |
| 127 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.41010469 |
| 128 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.36184589 |
| 129 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.35115596 |
| 130 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.34811847 |

